Dr. Thomas Smith joined Collegium Pharmaceutical in March of 2022 following the acquisition of BioDelivery Sciences International. Dr. Smith has more than twenty-five years of experience in a variety of leadership roles at various major pharmaceutical companies including serving as the Chief Medical Officer for BioDelivery Sciences International, Charleston Laboratories, Ameritox, and Mallinckrodt Pharmaceuticals. Prior to these, Dr. Smith served in scientific, medical, and clinical leadership roles at Abbott Laboratories, Teva Pharmaceuticals, and Kendle International. He is a member of several medical and scientific societies, including the American Medical Association and the American Academy of Family Physicians. Dr. Smith earned his M.D. from the Indiana University School of Medicine and a B.S. from Purdue University.